Poseida Therapeutics, Inc. (PSTX)

Poseida Therapeutics Revenue

Poseida Therapeutics had revenue of $71.75M in the quarter ending September 30, 2024, with 667.19% growth. This brings the company's revenue in the last twelve months to $150.86M, up 203.18% year-over-year. In the year 2023, Poseida Therapeutics had annual revenue of $64.70M, down -50.42%.

• Revenue (ttm): $150.86M
• Revenue Growth: +203.18%
• P/S Ratio: 1.74
• Revenue / Employee: $457,145
• Employees: 330
• Market Cap: 266.08M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	64.70M	-65.79M	-50.42%
Dec 31, 2022	130.49M	99.25M	317.73%
Dec 31, 2021	31.24M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.